As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 4 different industries.
|
| 57 | $790,102
As of Fiscal Year 2012 |
Background*
Dr. Maher Albitar, M.D. has been Chief Medical Officer and Director of Research & Development at NeoGenomics Laboratories, Inc. since January 2012. Dr. Albitar has been Chief Medical Officer and Director of Research & Development of Neogenomics Inc. since January 9, 2012. Dr. Albitar served as a Consultant of Health Discovery Corporation since November 15, 2012 and served as its Chief Medical Officer from May 2010 to April 7, 2011. Dr. Albitar has also served as a consultant ... to multiple companies. From 2008 to 2011, Dr. Albitar served as the Medical Director for Hematopathology and Oncology, Nichols Institute of Quest Diagnostics, and Chief R&D Director for Hematopathology and Oncology for Quest Diagnostics. From 2003 to 2008, Dr. Albitar served as the Director of Hematopathology for the Nichols Institute of Quest Diagnostics. Dr. Albitar served as the Chief Medical Officer of HDC from 2010 to 2011. His Academic Appointments includes: Professor, Tenured, Leukemia Department, Division of Medicine, The University of Texas MD Anderson Cancer Center since 2002, Professor, Tenured, Hematopathology Department, Division of Pathology & Laboratory Medicine, University of Texas MD Anderson Cancer Center from 2002 to 2003, Director of the Leukemia Tissue Bank, MD Anderson, Cancer Center from 2000 to 2003, Section Chief, Leukemia, Division of Laboratory Medicine and Pathology Medicine, University of Texas MD Anderson Cancer Center from 1999 to 2003 and Associate Professor, Leukemia Department, Division of Medicine, The University of Texas MD Anderson Cancer Center from 1999 to 2002. His Administrative Appointments includes: He has been member of the Board of Directors of Health Discover Corporation (HDC) from November 07, 2011 to November 15, 2012. D. Albitar was responsible for leading the Hematopathology department and coordinating the efforts of 20 hematopathologists throughout the Quest Diagnostics national network of laboratories. From 1991 to 2003, Dr. Albitar held various faculty positions at The University of Texas MD Anderson Cancer Center where he also served as Director of the Leukemia and Molecular Laboratory in the Division of Laboratory Medicine and Pathology Medicine. Dr. Albitar was based at Quest Diagnostics Nichols Institute in San Juan Capistrano, California, Quest Diagnostics Inc.'s center for research and development and one of its two full-service esoteric testing laboratories. Dr. Albitar is a renowned cancer scientist and was a tenured full Professor at M.D. Anderson Cancer Center and the University of Texas, where he served as chief of the hematopathology of the leukemia section with joint appointment in the clinical leukemia department. Dr. Albitar also established and developed numerous new techniques in clinical laboratory testing. Dr. Albitar has served as an expert on several national committees and editorial boards. Dr. Albitar is the principle inventor of more than 12 patents. From 2005 to 2011, Dr. Albitar also served as a Board member (Treasurer) of Associated Diagnostics Pathologists, Inc. He served as a Director of Health Discovery Corp. from April 7, 2011 to November 2012. He is the lead author or co-author of more than 250 peer-reviewed papers, which have been published in prominent medical journals, including Blood, Cancer, Leukemia, The European Journal of Hematology, Molecular and Cellular Biology and The New England Journal of Medicine. He has published extensively on angiogenesis in leukemia and he was the first to report on the presence of the circulating CD20 and CD52 diagnostic markers and their impact on the development of antibody-based therapy. Dr. Albitar is a recipient of a Physician Scientist Award from the U.S. National Institutes of Health and the American Cancer Society Fellowship Award. He has completed fellowships in hematopathology at the University of Pennsylvania School of Medicine, and in molecular biology and human genetics at the Howard Hughes Medical Institute at the University of Pennsylvania. Dr. Albitar has served on a variety of medical editorial review boards and is a frequent guest speaker at national and international conferences. He is board-certified in anatomic and clinical pathology with extensive experience in hematopathology. He holds numerous patents and has authored more than 300 peer-reviewed papers, book chapters, and review articles. His Teaching Includes: Lecturer, Tumor Immunology Course, The University of Texas M. D. Anderson Cancer Center, Houston, Texas in 2001, Lecturer, Physician Scientist Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas in 2001, Lecturer, core curriculum, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, in 1998 and Faculty Member, The University of Texas Graduate School of Biomedical Science, Houston, Texas from 1991 to 1998. His Certification includes : American Board of Anatomic Pathology in 1987 and American Board of Clinical Pathology in 1987. He has Licensures - Active, Texas Medical License,California Medical License and Rhode Island Board of Medical Licensure and Discipline License Pennsylvania Medical License. His Professional Memberships/Activities includes: American Association for the Advancement of Science, American Association for Cancer Research, American Society of Clinical Oncology, American Society of Hematology, Association for Molecular Pathology, College of American Pathologists and United States and Canadian Academy of Pathology. His Institutional Committee Activities includes: Quality Improvement Subcommittee of the Executive Committee of The Medical Staff from 1994 to 2003, Graduate Medical Education Review Subcommittee from 1998 to 2001, Graduate Medical Education Committee from 1994 to 2001, Fellowship Program Subcommittee from 1994 to 2001, Faculty Senate Clinical Issues Committee from 1994 to 1999, PRS Grant Review Committee from 1991 to 1998, Physician Scientist Program Committee from 1994 to 1997, Faculty Achievement Award Subcommittee, Education in 2001, Faculty Achievement Award Subcommittee, Clinical Research in 1998, Graduate Medical Education Budget Subcommittee in 1997, Research Retreat Planning Committee in 1996 and Research Institutional Direction Forum in 1995. His Honors and Awards includes: Patent Innovation Awards from Quest Diagnostics, Nichols Institute in 2008, Patent Innovation Award from Quest Diagnostics, Nichols Institute in 2006, Medical Innovation from Quest Diagnostics, Nichols Institute in 2005, Patent Innovation Award from Quest Diagnostics, Nichols Institute from 2005, American Society of Hematology Travel Award in 1989, American Cancer Society Fellowship in 1988, Physician Scientist Award from National Institutes of Health from 1988 to 1994 and Howard Hughes Medical Institute Fellowship Program from 1987 to 1988. His Education includes: Dr. Albitar received his medical degree in 1979 from Damascus Medical School in Damascus, Syria, He completed his Anatomic Pathology and
Corporate Headquarters*
12701 Common Wealth Drive
Fort Myers, Florida 33913
United States
Phone: 239-768-0600
Fax: 239-690-4237
Board Members Memberships*
2011-2012 Former Consultant
Education*
Post-Doctoral Training University of Pennsylvania MD 1979 Damascus Medical School In Damascus Syria
Other Affiliations*
|
Annual Compensation*
| Bonus | $98,775 | | Total Annual Compensation | $98,775 |
Stock Options*
| All Other Compensation | $404,978 | | Unexercisable Options | 250,000 | | Total Number of Options | 250,000 |
Total Compensation*
| Total Annual Cash Compensation | $503,753 | | Total Short Term Compensation | $98,775 | | Other Long Term Compensation | $404,978 | | Total Calculated Compensation | $790,102 |
|
*Data is at least as current as the most recent Definitive Proxy.
